Therapeutics and Clinical Risk Management · Published 2026-07-01 · DOI 10.2147/tcrm.s547154
Qiu-Chan Deng, Wen-Bin Kuang, Yu-Jing Yang, Cai-Ping Gong, Yi-Peng Zhang, Qiong Luo, Liu-Ping Luo, Guang-Ming Wang
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Deng, Q., Kuang, W., Yang, Y., et al. (2026). Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies. Therapeutics and Clinical Risk Management. https://doi.org/10.2147/tcrm.s547154